Oxytrol for Women
NDC 0023-9637, Oxybutynin, patch, from Allergan, Inc..
- Product NDC
- 0023-9637
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA202211
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9637 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN3.9 mg/d
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0023-9637-04 | 00023963704 | 16 PATCH in 1 CARTON (0023-9637-04) / 4 d in 1 PATCH |
| 0023-9637-08 | 00023963708 | 32 PATCH in 1 CARTON (0023-9637-08) / 4 d in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 00023963704
GET /v1/drugs/nadac/00023963704NADAC price for package 00023963708
GET /v1/drugs/nadac/00023963708
Use it
Look up 0023-9637 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9637 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0023-9637. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.